I agree with you partially. The clinicians and doctors who endorsed the summation and conclusion of the peer review must of had access to the data they produced and are verifying to the extent that they can, it is truthful. That Dr. Jin would be duplicitous in a scheme seems almost impossible . That EMA may have a different or modified view of the same data is plausible,IMO.
Market Data 
Markets 
AI
